Dr. PARTHA PRATIM ROY
Assistant Professor
Work Experience
11 Years
Area of Specialization
Pharmaceutical Chemistry, QSAR, QSTR, QSPR, Drug Design
Projects & Patents
1. UGC Start UP Grant : Computational prediction of Cytochrome P450 enzymes Inhibitors, 2013-2015 2. DST-SERB(EMR) :"Computational ecotoxicological modeling and risk assessment of selected classes of pesticides using chemometric tools" (2018-21)
Education
M.Pharm (Master in Pharmacy; Pharmaceutical Chemistry) Ph.D. PostDoc (ITALY)
Achievments/Awards/Honors
1. Listed in Worlds 2% Scientist list 2. Outstanding faculty in health and medical science
Publications
1. BW Matore, PP Roy, J Singh, Journal of Biomolecular Structure and Dynamics, 2023, 1-22 (IF : 5.20) 2. BW Matore, P Banjare, J Singh, PP Roy, Journal of Molecular Graphics and Modelling, 2022 116, 108238 (IF :2.942) 3. N Lakra, BW Matore, P Banjare, R Singh, J Singh, PP Roy, In Silico Pharmacology,2022, 1-18 4. P Banjare, J Singh, E Papa, PP Roy, Enviromental Science and pollution research, 2022,1-14 (IF :5.19) 5. BW Matore, P Banjare, T Guria, P P Roy, Jagadish Singh, European Journal of Medicinal Chemistry Reports, 2022 6. A Murmu, P Banjare, J Singh, PP Roy, International Journal of Quantitative Structure-PropertyRelationships,2022 7. UC Das… P P Roy, AK Sahoo, Journal of Ethnopharmacology 2022, 282, 114637(IF: 4.36) 8. P Banjare, B Matore, J Singh, PP Roy, In Silico Pharmacology ,2021, 9:28 9. P Banjare, J Singh, PP Roy, Enviromental Science and pollution research, 2021 28, 17992–18003 (IF :5.19) 10. A Vishvkarma, P Banjare, J Singh, PP Roy International Journal of Quantitative Structure-Property Relationships,2021 11. P Banjare, J Singh, PP Roy, International Journal of Quantitative Structure-PropertyRelationships, 2020,5, 73-99. 12. S kanhar PP Roy, AK Sahoo, J Sep Sci 2020, 43, 1566-1575(IF: 3.645) 13. PP Roy, P Banjare, S Verma, J SinghMolecularInformatics2019, 1-17. (IF: 2.375) 14. S Bajaj, PP Roy, J Singh, Journal of computationalBiology and Chemistry, 2018, 151-160. (IF: 1.581) 15. PP Roy, J Singh, S Ray, International Journal of Quantitative Structure-Property Relationships 2018, 3, 25-42. 16. S Bajaj, P Ghode, JSingh, PP Roy, S K Jain, Current Science,20182063-2071. (IF: 0.756) 17. P P Roy, S Bajaj, T K Maity, J Singh,.Indian Journal of Pharmaceutical Education and Research, 2017, 51, 260-269. (IF: 0.425) 18. P Banjare, J Singh, PP Roy ,Beni-Suef Uni. J. Bas. App. Sci. 2017, 219-231. 19. S Bajaj, PP Roy and J. Singh,Anti-Cancer Agents in Medicinal Chemistry, 2017, 1869-1883. (IF: 2.18) 20. A Gupta, R Raushan, J Singh and PP Roy, Lett Drug Des Discov.2016,1047-1054 (IF : 0.953) 21. S Bajaj, V Asati, J singh, PP Roy, European Journal of Medicinal Chemistry ,2015, 124-141 (IF : 5.572). 22. PP Roy, SD Ray, S Ray, BioorganicChemistry, 2014, 56, 1-7(IF: 4.831). 23. S Ray, S Mondal, SD Ray, PP Roy, MedicinalChemistryResearch2014, 4436-4446(IF: 1.720). 24. Cassani S, Kovarich S, Papa E, Roy PP , Vander wal L, Gramatica P. J. Haz Mat2013, 50-60 (IF: 14.224). 25. Gramatica P, Cassani S, Roy PP, Kovarich S, Yap CW, Papa E. MolecularInformatics2012,31 (11‐12), 817-835. (IF: 2.375) 26. Cassani S, KovarichS,Papa E, Roy PP, Rahmberg M, Nilsson S, Sahlin U, Jeliazkova N, Kochev N, PukalovO,Tetko I , Brandmaier S, Durjava M, Kolar B, Peijnenburg W, Gramatica P., ATLA 2013, 1–16 (IF: 3.014). 27. Ray S, Roy PP, Medicinal Chemistry, 2012,717-26(IF: 2.53). 28. Roy PP, Kovarich S, Gramatica P,J Comput Chem2011,32: 2386–2396 (IF: 4.05). 29. PranKishore D, Balakumar C, Raghuram Rao A, Roy PP, Roy K. Bioorg Med ChemLett, 2011,818-23 (IF: 2.66). 30. Roy PP and Roy K, J PharmPharmacol, 2010, 62: 1717-1728 (IF: 2.157). 31. Roy PP and Roy K, Molecular Simulation,2010,36: 887-905 (IF:1.215). 32. Roy PP and Roy K, Journal of Molecular Modeling2010,16: 1597–1616(IF:1.871). 33. Roy PP and Roy K, Molecular Simulation, 2010, 36: 311–325(IF:1.215). 34. Roy PP and Roy K, Journal of enzyme inhibition and medicinalchemistry, 2010, 25: 354–369 (IF: 1.57). 35. Mitra I, Roy PP, Kar S, Ojha P K, Roy K, Journal of Chemometrics,2010, 24: 22-33(IF:1.377). 36. Ray S, Roy PP, Sengupta C, Roy K, Molecular Simulation, 2010, 36: 484–492 (IF:1.215). 37. Roy K and Roy PP,Expert opinion on Metabolism and Toxicology, 2009, 5: 1245-1266(IF: 3.374). 38. Roy PP and Roy K, Chem. Biol drug Des. 2009, 73:442-455(IF:2.527).. 39. Roy K, Roy PP,European Journal of MedicinalChemistry2009, 44; 2913-2922(IF: 5.572). 40. Roy K, Roy PP, European Journal of MedicinalChemistry2009, 44: 1941-1951(IF: 5.572). . 41. Ray SD, Roy PP,Ray S, Acta Pharm. 2009, 59: 325–334(IF: 0.91). 42. Roy PP, Paul S, Mitra I, Roy K, Molecules,2009, 14: 1660-1701(IF: 1.988). 43. Roy PP& Roy K, QSAR CombSci, 2008: 27, 302-313. 44. Roy PP, Leonard J T & Roy K, ChemomIntellLab Sys, 2008: 90, 31-42. 45. Roy K, Roy PP, ChemBiol Drug Des. 2008, 71: 464-471(IF: 2.527). 46. Roy K, Roy PP, Chem. BiolDrug Des.2008, 72: 370-382(IF:2.527).. 47. Roy K, Sanyal I and Roy PP, SAR QSAR Environ. Res., 2006,17: 563–582 (IF: 2.287).